FilingReader Intelligence
Sino Biopharm profit surges 140% on innovative products
August 18, 2025 at 08:39 AM UTC•By FilingReader AI
Sino Biopharmaceutical reported profit attributable to owners from continuing operations surged 140.2% to RMB3.39 billion for the six months ended June 30. Revenue rose 10.7% to RMB17.57 billion.
Sales of innovative products reached RMB7.80 billion, up 27.2% and representing 44.4% of total revenue. Oncology medicine sales grew 24.9% to RMB6.69 billion.
The company declared an interim dividend of HK5 cents per share.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1177•Hong Kong Exchange
News Alerts
Get instant email alerts when Sino Biopharmaceutical publishes news
Free account required • Unsubscribe anytime